alanine has been researched along with Hepatitis C, Chronic in 12 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with HCV GT3 infection and/or liver cirrhosis were excluded." | 2.90 | JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1. ( Ackaert, O; Aghemo, A; Beumont, M; Biermer, M; Bourgeois, S; Buggisch, P; Buti, M; Corbett, C; Fevery, B; Greenbloom, S; Janczewska, E; Kalmeijer, R; Lampertico, P; Lim, SG; Moreno, C; Ouwerkerk-Mahadevan, S; Sinha, R; Tam, E; Vijgen, L; Willems, W; Zeuzem, S, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 7 (58.33) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, KA | 1 |
| Dangerfield, T | 1 |
| Fujita, Y | 1 |
| Shytaj, IL | 1 |
| Fares, M | 1 |
| Gallucci, L | 1 |
| Lucic, B | 1 |
| Tolba, MM | 1 |
| Zimmermann, L | 1 |
| Adler, JM | 1 |
| Xing, N | 1 |
| Bushe, J | 1 |
| Gruber, AD | 1 |
| Ambiel, I | 1 |
| Taha Ayoub, A | 1 |
| Cortese, M | 1 |
| Neufeldt, CJ | 1 |
| Stolp, B | 1 |
| Sobhy, MH | 1 |
| Fathy, M | 1 |
| Zhao, M | 1 |
| Laketa, V | 1 |
| Diaz, RS | 1 |
| Sutton, RE | 1 |
| Chlanda, P | 1 |
| Boulant, S | 1 |
| Bartenschlager, R | 1 |
| Stanifer, ML | 1 |
| Fackler, OT | 1 |
| Trimpert, J | 1 |
| Savarino, A | 1 |
| Lusic, M | 1 |
| Surial, B | 1 |
| Cavassini, M | 1 |
| Calmy, A | 1 |
| Fehr, J | 1 |
| Stöckle, M | 1 |
| Bernasconi, E | 1 |
| Roth, B | 1 |
| Fux, CA | 1 |
| Kovari, H | 1 |
| Furrer, H | 1 |
| Rauch, A | 1 |
| Wandeler, G | 1 |
| Takehara, T | 1 |
| Chayama, K | 1 |
| Kurosaki, M | 1 |
| Yatsuhashi, H | 1 |
| Tanaka, Y | 1 |
| Hiramatsu, N | 1 |
| Sakamoto, N | 1 |
| Asahina, Y | 1 |
| Nozaki, A | 1 |
| Nakano, T | 1 |
| Hagiwara, Y | 1 |
| Shimizu, H | 1 |
| Yoshida, H | 1 |
| Huang, Y | 1 |
| Biermer, M | 2 |
| Vijgen, L | 2 |
| Hayashi, N | 1 |
| Leungsuwan, S | 1 |
| Hooi, B | 1 |
| Myint, KS | 1 |
| Schloer, S | 1 |
| Brunotte, L | 1 |
| Mecate-Zambrano, A | 1 |
| Zheng, S | 1 |
| Tang, J | 1 |
| Ludwig, S | 1 |
| Rescher, U | 1 |
| Gammeltoft, KA | 1 |
| Zhou, Y | 1 |
| Duarte Hernandez, CR | 1 |
| Galli, A | 1 |
| Offersgaard, A | 1 |
| Costa, R | 1 |
| Pham, LV | 1 |
| Fahnøe, U | 1 |
| Feng, S | 1 |
| Scheel, TKH | 1 |
| Ramirez, S | 1 |
| Bukh, J | 1 |
| Gottwein, JM | 1 |
| Valade, E | 1 |
| Kakuda, TN | 1 |
| McClure, MW | 1 |
| Westland, C | 1 |
| Valenzuela, B | 1 |
| Ouwerkerk-Mahadevan, S | 2 |
| Perez-Ruixo, JJ | 1 |
| Ackaert, O | 2 |
| Zeuzem, S | 1 |
| Bourgeois, S | 1 |
| Greenbloom, S | 1 |
| Buti, M | 1 |
| Aghemo, A | 1 |
| Lampertico, P | 1 |
| Janczewska, E | 1 |
| Lim, SG | 1 |
| Moreno, C | 1 |
| Buggisch, P | 1 |
| Tam, E | 1 |
| Corbett, C | 1 |
| Willems, W | 1 |
| Fevery, B | 1 |
| Beumont, M | 1 |
| Kalmeijer, R | 1 |
| Sinha, R | 1 |
| Stickel, F | 1 |
| Osterreicher, CH | 1 |
| Datz, C | 1 |
| Ferenci, P | 1 |
| Wölfel, M | 1 |
| Norgauer, W | 1 |
| Kraus, MR | 1 |
| Wrba, F | 1 |
| Hellerbrand, C | 1 |
| Schuppan, D | 1 |
| Nomura, H | 1 |
| Miyake, K | 1 |
| Hirakata, R | 1 |
| Migita, S | 1 |
| Okamoto, O | 1 |
| Shiraishi, G | 1 |
1 review available for alanine and Hepatitis C, Chronic
| Article | Year |
|---|---|
Mechanisms of inhibition of viral RNA replication by nucleotide analogs.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Hepatitis C, Chronic; Humans; Kinetics | 2021 |
4 trials available for alanine and Hepatitis C, Chronic
| Article | Year |
|---|---|
JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study.
Topics: Adult; Aged; Alanine; Antiviral Agents; Benzimidazoles; Carbamates; Drug Combinations; Female; Follo | 2020 |
Population Pharmacokinetics of AL-335 and Its Two Main Metabolites (ALS-022399, ALS-022227) in Monotherapy and in Combination with Odalasvir and/or Simeprevir.
Topics: Administration, Oral; Alanine; Antiviral Agents; Benzimidazoles; Biological Variation, Population; C | 2018 |
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1.
Topics: Adult; Aged; Alanine; Antiviral Agents; Benzimidazoles; Carbamates; Dose-Response Relationship, Drug | 2019 |
Rebamipide prevents occurrence of gastric lesions following transcatheter arterial embolization in the hepatic artery.
Topics: Adult; Aged; Alanine; Carcinoma, Hepatocellular; Embolization, Therapeutic; Esophageal and Gastric V | 1999 |
7 other studies available for alanine and Hepatitis C, Chronic
| Article | Year |
|---|---|
[Remdesivir for COVID-19].
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19 Drug Treatment; Hemorrhagic Fe | 2022 |
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Cobicistat; COVID-19 Drug Treatment; Cr | 2022 |
Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort.
Topics: Adenine; Adult; Alanine; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Drug Interactions; F | 2019 |
Hypophosphatemic Osteomalacia Due to Adefovir-Induced Fanconi Syndrome.
Topics: Adenine; Aged; Alanine; Antiviral Agents; Fanconi Syndrome; Female; Hepatitis C, Chronic; Humans; Hy | 2020 |
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19 Drug Treatment; Fluoxetine; Hepatitis C | 2021 |
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Chlorocebus aethiops; COVID-19 Drug Tre | 2021 |
Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Disease Progression; Female; Genotype; Glutathione Transfer | 2005 |